SCHEMBL14565007

SCHEMBL14565007

COC(=O)c1ccc2sc(=O)[nH]c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.50
KIF11 P52732 1/20 0.50
CMA1 P23946 1/20 0.50
CREBBP Q92793 1/20 0.49
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
PDE3B Q13370 2/20 0.47
PDE3A Q14432 2/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
CSNK2A1 P68400 1/20 0.45
HTT P42858 2/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
XDH P47989 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28097716 0.89 PDE3B (0.57) PARP1KIF11CREBBPKDM4EALDH1A1
SCHEMBL10650863 0.82 CMA1 (0.54) KIF11CMA1KDM4EALDH1A1HPGD
SCHEMBL2317568 0.80 CMA1 (0.56) PARP1CMA1KDM4EALDH1A1HPGD
SCHEMBL10619933 0.78 CMA1 (0.50) CMA1PDE3BPDE3ASMN1; SMN2L3MBTL1
SCHEMBL10651846 0.76 CMA1 (0.47) CMA1KDM4EALDH1A1HPGDPDE3B
SCHEMBL28933680 0.75 CMA1 (0.54) CMA1KDM4EALDH1A1PDE3BPDE3A
SCHEMBL10653121 0.75 CMA1 (0.50) PARP1CMA1PDE3BPDE3A
SCHEMBL10859212 0.75 CMA1 (0.46) KIF11CMA1KDM4EALDH1A1HPGD
SCHEMBL10859216 0.75 CMA1 (0.46) KIF11CMA1KDM4EALDH1A1HPGD
SCHEMBL7767367 0.74 HCRTR1 (0.65) PARP1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022135355-A1 METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR 内蒙古工业大学 2022-06-30 WO disclosed
WO-2022135355-A1 METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR 内蒙古工业大学 2022-06-30 WO disclosed
CN-114644603-A Method for catalytically activating carbon dioxide as carbonylation reagent by using inorganic sulfur 内蒙古工业大学 2022-06-21 CN disclosed
US-20070054899-A1 Aromatase inhibitor compounds and uses thereof PARALLEL WIRELESS, INC. 2007-03-08 US disclosed
US-20070054899-A1 Aromatase inhibitor compounds and uses thereof PARALLEL WIRELESS, INC. 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054899-A1 Aromatase inhibitor compounds and uses thereof CYP19A1, CYP17A1, HSD17B11 PARP1 1538/4885KIF11 3600/4885CMA1 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.